Correlation Between E Split and Aptose Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both E Split and Aptose Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining E Split and Aptose Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between E Split Corp and Aptose Biosciences, you can compare the effects of market volatilities on E Split and Aptose Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in E Split with a short position of Aptose Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of E Split and Aptose Biosciences.

Diversification Opportunities for E Split and Aptose Biosciences

-0.83
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between ENS-PA and Aptose is -0.83. Overlapping area represents the amount of risk that can be diversified away by holding E Split Corp and Aptose Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aptose Biosciences and E Split is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on E Split Corp are associated (or correlated) with Aptose Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aptose Biosciences has no effect on the direction of E Split i.e., E Split and Aptose Biosciences go up and down completely randomly.

Pair Corralation between E Split and Aptose Biosciences

Assuming the 90 days trading horizon E Split Corp is expected to generate 0.06 times more return on investment than Aptose Biosciences. However, E Split Corp is 15.74 times less risky than Aptose Biosciences. It trades about 0.15 of its potential returns per unit of risk. Aptose Biosciences is currently generating about -0.02 per unit of risk. If you would invest  1,053  in E Split Corp on October 12, 2024 and sell it today you would earn a total of  71.00  from holding E Split Corp or generate 6.74% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

E Split Corp  vs.  Aptose Biosciences

 Performance 
       Timeline  
E Split Corp 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in E Split Corp are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, E Split may actually be approaching a critical reversion point that can send shares even higher in February 2025.
Aptose Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Aptose Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in February 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

E Split and Aptose Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with E Split and Aptose Biosciences

The main advantage of trading using opposite E Split and Aptose Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if E Split position performs unexpectedly, Aptose Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aptose Biosciences will offset losses from the drop in Aptose Biosciences' long position.
The idea behind E Split Corp and Aptose Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum